Silvan Turkcan
Stock Analyst at Citizens
(0.94)
# 4,201
Out of 5,182 analysts
3
Total ratings
33.33%
Success rate
-3.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Silvan Turkcan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLAY Relay Therapeutics | Maintains: Market Outperform | $15 → $17 | $13.48 | +26.11% | 1 | Mar 17, 2026 | |
| NTLA Intellia Therapeutics | Maintains: Market Outperform | $21 → $28 | $13.55 | +106.64% | 1 | Mar 3, 2026 | |
| CRSP CRISPR Therapeutics AG | Maintains: Market Outperform | $86 → $80 | $49.70 | +60.97% | 1 | Jan 30, 2026 |
Relay Therapeutics
Mar 17, 2026
Maintains: Market Outperform
Price Target: $15 → $17
Current: $13.48
Upside: +26.11%
Intellia Therapeutics
Mar 3, 2026
Maintains: Market Outperform
Price Target: $21 → $28
Current: $13.55
Upside: +106.64%
CRISPR Therapeutics AG
Jan 30, 2026
Maintains: Market Outperform
Price Target: $86 → $80
Current: $49.70
Upside: +60.97%